Today: 21 May 2026
Rocket Lab (RKLB) stock slides 10% as Mars sample-return hopes fade — what investors watch next
5 February 2026
2 mins read

Rocket Lab (RKLB) stock slides 10% as Mars sample-return hopes fade — what investors watch next

New York, Feb 4, 2026, 21:04 EST — The market has closed.

  • Rocket Lab shares plunged Wednesday, closing out a volatile week marked by sudden shifts.
  • Washington’s move to put NASA’s Mars Sample Return plan on hold has cast a shadow over space-sector stocks.
  • Attention turns to Rocket Lab’s February 26 earnings report and any news on its Neutron rocket development.

Rocket Lab Corp shares dropped 10.0%, closing Wednesday at $73.11 after falling from an $81.35 opening to a low of $68.56 during the session. After-hours trading saw the stock edge up slightly to $73.35. This marks the third consecutive session of sharp swings.

Traders aren’t focused on the latest Rocket Lab quarter. Instead, it’s all about how fast space stocks react to government spending news and what the market currently makes of the so-called “SpaceX trade.”

Rocket Lab is feeling pressure from Washington after Congress refused to fund a 2031 mission aimed at returning Mars samples, linked to NASA’s Perseverance rover, Benzinga reported. The company had pitched a $4 billion plan for this long-term project, which had become a key sentiment driver for its stock.

The underlying program has faced mounting pressure for months amid rising costs and tighter budgets from lawmakers. On Jan. 8, a House “minibus” spending package wiped out funding for Mars Sample Return, effectively canceling the project, Scientific American reported. Meanwhile, Congress still allocated funds for other Mars initiatives. Scientific American

Rocket Lab saw a jump the day before, as the sector became a stand-in for Elon Musk’s latest play. On Tuesday, the stock climbed 3.9% after Musk unveiled plans to merge SpaceX with xAI, valuing the new entity at $1.25 trillion, according to Reuters. Planet Labs nudged up 1.2%, AST SpaceMobile gained 4.3%, and Intuitive Machines added 4.7%. “Others may buy into Musk’s grand vision of data centers in the cosmos,” said AJ Bell investment director Russ Mould. Seraphim Space CEO Mark Boggett described it as “the strongest validation yet that space will be the backbone of the next wave of AI.” Reuters

Rocket Lab has focused on execution and launch frequency. After completing its 81st Electron mission, founder and CEO Sir Peter Beck noted in a Jan. 29 statement, “Two launches in eight days is a strong start to the year.” GlobeNewswire

Investors, however, face a broader set of concerns than just Electron. In a Jan. 21 filing, Rocket Lab revealed that qualification testing of a Neutron stage-1 tank ended with a rupture during a hydrostatic pressure test—a ground-based stress check. The company is now analyzing the data to determine what, if any, effect this might have on Neutron’s launch timeline.

The immediate risk? A sector valued for growth, with volatile headlines and the next catalyst possibly coming from Congress, Musk, or Rocket Lab’s schedule. If investors stop seeing long-term NASA projects as just bonus potential, the stock’s baseline could shift dramatically.

Rocket Lab is set to release its Q4 and full-year 2025 earnings after U.S. markets close on Thursday, Feb. 26, followed by a conference call at 5 p.m. Eastern. Investors will focus on 2026 launch cadence goals, demand for space systems, and any updates on the Neutron rocket’s development.

Stock Market Today

  • Trump Bought Eli Lilly Stock Amid Government Support for Obesity Drugs
    May 21, 2026, 9:17 AM EDT. President Donald Trump purchased up to $680,000 in Eli Lilly stock earlier in 2024 as his administration advanced policies benefiting the drugmaker's obesity medications. The purchases, disclosed in ethics filings, coincided with government moves toward Medicare reimbursement for GLP-1 obesity drugs, a significant financial boost for Lilly. The Centers for Medicare & Medicaid Services proposed pilot programs to reduce patient costs, prompting Lilly's inclusion. Trump also invested between $250,000 and $500,000 in West Pharmaceutical Services, which supplies injection devices linked to GLP-1 drugs. Both companies have seen financial gains tied to the expanding obesity drug market. The Department of Health and Human Services, White House, and Trump Organization declined detailed comments.

Latest articles

POET Eyes $400 Million Raise as Traders Focus on Key Risk

POET Eyes $400 Million Raise as Traders Focus on Key Risk

21 May 2026
POET Technologies shares fell in premarket trading Thursday after a $400 million direct offering of 19.05 million shares and warrants. The stock closed Wednesday at $14.78, up 13.1%, but slipped to $14.38 before the open. Proceeds will fund a major manufacturing expansion. The sole buyer was MMCAP International Inc. SPC.
MARA Stock Just Jumped — Now Its $1.5 Billion AI Power Bet Faces a Test

MARA Stock Just Jumped — Now Its $1.5 Billion AI Power Bet Faces a Test

21 May 2026
MARA Holdings shares slipped to $13.10 in pre-market trading Thursday after a 5.7% jump, as insider filings showed CEO Fred Thiel and CFO Salman Khan sold shares at $12 each under pre-arranged plans. The moves follow MARA’s $1.5 billion deal to acquire Long Ridge Energy & Power, adding a 505-megawatt Ohio gas plant and land for AI-focused data centers. The transaction awaits regulatory approval and is expected to close in late 2026.
Nvidia Shares Flat After Big Earnings Beat as Street Looks for More

Nvidia Shares Flat After Big Earnings Beat as Street Looks for More

21 May 2026
Nvidia reported first-quarter revenue of $81.6 billion, up 85% from a year earlier, and forecast $91 billion for the second quarter, topping Wall Street estimates. Shares were little changed premarket at $223.29 despite the strong results and an $80 billion share buyback announcement. Data-center revenue rose 92% to $75.2 billion. Nvidia raised its quarterly dividend to 25 cents from 1 cent.
KKR stock jumps after-hours as $5.2 billion data-center deal lands before earnings
Previous Story

KKR stock jumps after-hours as $5.2 billion data-center deal lands before earnings

Anglo American share price slips after copper output drop, 2026 guidance cut
Next Story

Anglo American share price slips after copper output drop, 2026 guidance cut

Go toTop